Double-drug development against antioxidant enzymes fromPlasmodium falciparum
نویسندگان
چکیده
منابع مشابه
Nucleoredoxin guards against oxidative stress by protecting antioxidant enzymes.
Cellular accumulation of reactive oxygen species (ROS) is associated with a wide range of developmental and stress responses. Although cells have evolved to use ROS as signaling molecules, their chemically reactive nature also poses a threat. Antioxidant systems are required to detoxify ROS and prevent cellular damage, but little is known about how these systems manage to function in hostile, R...
متن کاملDevelopment of target focused library against drug target of P. falciparum using SVM and Molecular docking
PfHslV, a homolog of b subunit of 20S proteasome forms the proteolytic core of the PfHslUV machinery in P. falciparum [1,2]. PfHslV has no homolog in the human host and it is a promising drug target essential to the plasmodial metabolism. The use of single proteasome inhibitor targeting these threonine proteases has a potential to be antimalarial drug candidate. One of our recent studies identi...
متن کاملAssessing drug efficacy against Plasmodium falciparum liver stages in vivo.
Malaria eradication necessitates new tools to fight the evolving and complex Plasmodium pathogens. These tools include prophylactic drugs that eliminate Plasmodium liver stages and consequently prevent clinical disease, decrease transmission, and reduce the propensity for resistance development. Currently, the identification of these drugs relies on in vitro P. falciparum liver stage assays or ...
متن کاملDrug Development Against Metastatic Cancers
While combinational diagnostic and treatment strategies over the past decades have significantly improved the overall survival of cancer patients, metastatic cancer remains a leading cause of death in developed countries. The lack of successful treatment strategies for the disease is in large part due to the complexity of the metastatic transformation, which embodies extensive cellular and extr...
متن کاملStrategies & recent development of transmission-blocking vaccines against Plasmodium falciparum
Transmission blocking malaria vaccines are aimed to block the development and maturity of sexual stages of parasite within mosquitoes. The vaccine candidate antigens (Pfs25, Pfs48/45, Pfs230) that have shown transmission blocking immunity in model systems are in different stages of development. These antigens are immunogenic with limited genetic diversity. Pfs25 is a leading candidate and curre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Redox Report
سال: 2003
ISSN: 1351-0002,1743-2928
DOI: 10.1179/135100003225002916